- Home
- ICLR vs AXTA Comparison
ICLR vs AXTA Comparison
Compare ICLR & AXTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | AXTA |
|---|---|---|
| Founded | 1990 | 1910 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Paints/Coatings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 7.7B |
| IPO Year | 2001 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ICLR | AXTA |
|---|---|---|
| Price | $172.48 | $34.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $178.62 | $35.23 |
| AVG Volume (30 Days) | 532.6K | ★ 1.5M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $5,117,000,000.00 |
| Revenue This Year | N/A | $3.60 |
| Revenue Next Year | N/A | $3.26 |
| P/E Ratio | ★ $12.91 | $82.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $66.57 | $24.94 |
| 52 Week High | $203.91 | $38.61 |
Technical Indicators
Market Signals| Indicator | ICLR | AXTA |
|---|---|---|
| Relative Strength Index (RSI) | 49.24 | 37.76 |
| Support Level | $162.06 | $33.24 |
| Resistance Level | $183.11 | $35.48 |
| Average True Range (ATR) | 5.66 | 0.76 |
| MACD | -0.90 | -0.34 |
| Stochastic Oscillator | 34.81 | 0.72 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
About AXTA Axalta Coating Systems Ltd.
Axalta Coating Systems Ltd is a manufacturer, marketer, and distributor of high-performance coatings systems. It operates in two segments: Performance Coatings and Mobility Coatings. The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial, and the Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The majority of its revenue is generated from the Mobility Coatings segment. Geographically, the company generates maximum revenue from the Europe, Middle East and Africa (EMEA) region, followed by North America, Asia Pacific, and Latin America.